Decreased Bell's phenomenon after inferior and medial orbital wall decompression in thyroid-associated ophthalmopathy: a double-edged sword in management of the patients
- PMID: 34851466
- DOI: 10.1007/s00417-021-05509-1
Decreased Bell's phenomenon after inferior and medial orbital wall decompression in thyroid-associated ophthalmopathy: a double-edged sword in management of the patients
Abstract
Purpose: To evaluate the changes in Bell's phenomenon after inferior and medial orbital wall decompression in patients with thyroid-associated ophthalmopathy (TAO).
Methods: This prospective interventional study included patients with moderate to severe non-active TAO, who underwent inferior and medial wall orbital decompression. Bell's phenomenon and adjusted Bell's phenomenon were evaluated at baseline and six months after surgery. Bell's phenomenon was assessed by holding the upper lid open during forced eyelid closure. Afterwards, the upward excursion, the distance between lower eyelid margin and lower corneal limbus, was measured. Adjusted Bell's phenomenon distance is defined as the difference between margin reflex distance two (MRD2) and Bell's phenomenon distance.
Results: Thirty TAO patients, including 15 males (50%), with a mean age of 43.6 ± 11.6 years, were enrolled. The distance of Bell's phenomenon significantly decreased after surgery by an average of 3.25 ± 1.57 mm (P < 0.001). In addition, the difference between pre- and post-operative distance of adjusted Bell's phenomenon was - 1.58 ± 2.13 (P < 0.001) corresponding to the worsening in the adjusted Bell's phenomenon.
Conclusion: The result of our study demonstrated that Bell's phenomenon decreases significantly after inferior and medial wall decompression, which could be considered a complication of this form of orbital wall decompression in TAO.
Keywords: Bell’s phenomenon; Graves; Ophthalmopathy; Orbital wall decompression; Thyroid-associated ophthalmopathy.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Bell's phenomenon in thyroid-associated inferior rectus myopathy.Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2467-2471. doi: 10.1007/s00417-017-3792-9. Epub 2017 Sep 1. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28861686
-
Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy.Korean J Ophthalmol. 2016 Feb;30(1):1-9. doi: 10.3341/kjo.2016.30.1.1. Epub 2016 Jan 21. Korean J Ophthalmol. 2016. PMID: 26865797 Free PMC article.
-
Surgical Outcomes of Balanced Deep Lateral and Medial Orbital Wall Decompression in Korean Population: Clinical and Computed Tomography-based Analysis.Korean J Ophthalmol. 2016 Apr;30(2):85-91. doi: 10.3341/kjo.2016.30.2.85. Epub 2016 Mar 25. Korean J Ophthalmol. 2016. PMID: 27051255 Free PMC article.
-
Secondary Effects of Orbital Decompression in Thyroid Eye Disease: A Review.Semin Ophthalmol. 2023 Jul;38(5):465-474. doi: 10.1080/08820538.2023.2166354. Epub 2023 Jan 11. Semin Ophthalmol. 2023. PMID: 36631972 Review.
-
[Re-evaluate the value of orbital decompression for thyroid associated ophthalmopathy].Zhonghua Yan Ke Za Zhi. 2017 Jun 11;53(6):401-403. doi: 10.3760/cma.j.issn.0412-4081.2017.06.001. Zhonghua Yan Ke Za Zhi. 2017. PMID: 28606259 Review. Chinese.
Cited by
-
Novel immunoinflammatory blood markers in Graves' orbitopathy: insights into activity and severity.BMJ Open Ophthalmol. 2024 Dec 17;9(1):e001744. doi: 10.1136/bmjophth-2024-001744. BMJ Open Ophthalmol. 2024. PMID: 39694546 Free PMC article.
-
Ocular surface lesions in clinical grades of Bell's phenomenon.Med Hypothesis Discov Innov Ophthalmol. 2024 Jan 31;12(4):177-186. doi: 10.51329/mehdiophthal1484. eCollection 2023 Winter. Med Hypothesis Discov Innov Ophthalmol. 2024. PMID: 38601052 Free PMC article.
References
-
- Muñoz-Ortiz J, Sierra-Cote MC, Zapata-Bravo E et al (2020) Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: a systematic review of the literature. Syst Rev 9(1):201 - DOI
-
- Antonelli A, Fallahi P, Elia G et al (2020) Graves’ disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab 34(1):101388 - DOI
-
- Akbari M, Bayat R, Mirmohammadsadeghi A et al (2020) Strabismus surgery in thyroid-associated ophthalmopathy; surgical outcomes and surgical dose responses. J Binocul Vis Ocul Motil 70(4):150–156 - DOI
-
- Łacheta D, Miśkiewicz P, Głuszko A et al (2019) Immunological Aspects of Graves’ Ophthalmopathy. Biomed Res Int 2019:7453260 - DOI
-
- Khatavi F, Nasrollahi K, Zandi A et al (2017) A promising modified procedure for upper eyelid retraction-associated Graves’ ophthalmopathy: transconjunctival lateral levator aponeurectomy. Med Hypothesis Discov Innov Ophthalmol 6(2):44–48
MeSH terms
LinkOut - more resources
Full Text Sources